1 completed, 1 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Corneal Opacity: new trials by email Literature Review of Corneal Opacity trials Research Report on Corneal Opacity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft Biopsy to collect limbal epithelial stem cells that will be cultivated into a graft, Cultivation of Limbal epithelial cells into a graft, CALEC Transplant - Limbal Stem Cell Deficiency | Phase 1 / Phase 2 | Completed | Massachusetts Eye and Ear Infirmary | 23 | 2016-08-01 | 2025-01-15 |
| The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements Mitomycin-C, Fluorometholone 1% topical ocular steroid - Corneal Opacity | Phase 2 / Phase 3 | Unknown | United States Naval Medical Center, San Diego | 300 | 2014-08-01 | 2022-04-15 |
Corneal Injuries (1) · Corneal Neovascularization (1) · Eye Injuries (1) · Limbal Stem Cell Deficiency (1)
Corneal Diseases (2) · Eye Diseases (2) · Craniocerebral Trauma (1) · Facial Injuries (1) · Metaplasia (1) · Neovascularization, Pathologic (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
Fluorometholone (1) · Mitomycin (1)
Massachusetts Eye and Ear Infirmary (1) · United States Naval Medical Center, San Diego (1)
United States (2)
Donna Murdoch, Ph.D. (1) · John B Cason, M.D. (1) · Ula Jurkunas, MD (1)